Crystalline forms of rabeprazole sodium
    3.
    发明申请
    Crystalline forms of rabeprazole sodium 审中-公开
    雷贝拉唑钠的结晶形式

    公开(公告)号:US20050234103A1

    公开(公告)日:2005-10-20

    申请号:US10505826

    申请日:2003-03-25

    CPC分类号: C07D401/12

    摘要: The present invention relates to novel polymorphic forms of Rabeprazole sodium. The present invention also relates to methods of making polymorphic forms of Rabeprazole sodium. Achiphex7 (Rabeprazole sodium) is an inhibitor of the gastric proton pump. It causes dose-dependant inhibition of acid secretion and is useful as an antiulcer agent. The chemical designation of Rabeprazole sodium is 2-[[[4-(3-methoxypropoxy)-3 methyl-2-pyridinyl]-methyl]sulfinyl]-1H-benzimidazole sodium. It may be represented by Formula (1).

    摘要翻译: 本发明涉及雷贝拉唑钠的新型多晶型物。 本发明还涉及制备雷贝拉唑钠的多晶型物的方法。 Achiphex7(雷贝拉唑钠)是胃质子泵的抑制剂。 它导致酸分泌的剂量依赖性抑制,并且可用作抗溃疡剂。 雷贝拉唑钠的化学名称是2 - [[[4-(3-甲氧基丙氧基)-3-甲基-2-吡啶基] - 甲基]亚磺酰基] -1H-苯并咪唑钠。 它可以由公式(1)表示。